Teladoc CEO Jason Gorevic to leave the company

In a decision that surprised Wall Street analysts, Teladoc Health announced that long-time CEO Jason Gorevic will depart the company immediately.

In a statement, the board of directors said, CFO Mala Murthy will take over as the acting chief executive.

The leadership change comes as the virtual care company hunts for a path forward after a period of explosive growth during the Covid-19 pandemic. In February the company projected it would see single-digital growth for the next several years. Teladoc shares are down from its 2021 high of around $294, with the stock currently trading at around $14 a share.

Get unlimited access to award-winning journalism and exclusive events.

Scientists discover brain’s ‘future map’

Researchers from the RIKEN Center for Brain Science (CBS) in Japan have discovered a region of the brain that encodes where an animal is planning

August 16, 2024

AstraZeneca to build $1.5bn ADC production facility in Singapore

The ADC manufacturing facility in Singapore is set to enhance global cancer treatment supply. Credit: Volodymyr Horbovyy / Shutterstock.com. AstraZeneca is set to invest $1.5bn

May 21, 2024

Biologics Offer New Options in Atopic Dermatitis

In this exclusive MedPage Today video, Peter Lio, MD, of Northwestern University Feinberg School of Medicine in Chicago, talks about how excited he is to

December 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.